Faron Pharmaceuticals Investor Relations Material
Latest events
Study Result
Faron Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Faron Pharmaceuticals
Access all reports
Faron Pharmaceuticals is a Finland-based clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer and other serious conditions. The company’s research targets immune system modulation to treat aggressive diseases with unmet medical needs. Faron Pharmaceuticals is headquartered in Turku, Finland, and its shares are listed on the AIM.
Key slides for Faron Pharmaceuticals
CMD 2024
Faron Pharmaceuticals
CMD 2024
Faron Pharmaceuticals
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
FARON
Country
🇫🇮 Finland